DCGI Approves Advanced Trials for Biological E. Limited’s COVID- 19 Vaccine
The Drugs Controller General of India (DCGI) has approved Hyderabad-based Biological E. Limited for conducting Phase III comparator safety and immunogenicity trial in adults of its CORBEVAX™ vaccine against COVID-19 after Subject Expert…
Read More...
Read More...